858 Therapeutics Secures $50M Series B Financing to Advance Oncology Therapeutics
Key Highlights 858 Therapeutics raises $50M in Series B financing led by Avidity Partners. Proceeds to advance ETX-19477, a selective…
Browsing Tag
Mirae Asset Capital
1 post